Restless legs syndrome in a group of patients with Alzheimer's disease

American Journal of Alzheimer's Disease and other Dementias

Volumn 28, Issue 2, 2013, Pages 165-170

  Talarico, Giuseppina ^a   Canevelli, M ^a   Tosto, G ^a   Vanacore, N ^b   Letteri, F ^a   Prastaro, M ^a   Troili, F ^a   Gasparini, M ^a   Lenzi, G L ^a   Bruno, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Alzheimer's disease; apathy; dopaminergic dysfunction; neurodegenerative disease; restless legs syndrome; sleep disorders

Indexed keywords

ANTIDEPRESSANT AGENT; CHOLINESTERASE INHIBITOR; FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ALZHEIMER DISEASE; APATHY; ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; RECALL; RESTLESS LEGS SYNDROME; SCORING SYSTEM; SEX RATIO; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 84876523230     PISSN: 15333175     EISSN: 19382731     Source Type: Journal    
DOI: 10.1177/1533317512470208     Document Type: Article

References (27)

1. Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact. REST general population study. Arch Inter Med. 2005 ; 165 (11). 1286-1292
2. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations and epidemiology. Sleep Med. 2003 ; 4 (2). 101-109
3. Cervenka S, Palhagen SE, Comley RA, et al. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain. 2006 ; 129: 2017-28
4. Ondo WG. Restless legs syndrome. Curr Neurol Neurosci Rep. 2005 ; 5 (4). 266-274
5. Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology. 2000 ; 54 (8). 1698-1700
6. Mizuno S, Mihara T, Miyaoka T, Inagaki T, Horiguchi J. CSF iron, ferritin, and transferrin levels in restless legs syndrome. J Sleep Res. 2005 ; 14 (1). 43-47
7. Iranzo A, Comella CL, Santamaria J, Oertel W. Restless legs syndrome in Parkinson's disease and other neurodegenerative diseases of the central nervous system. Movement Disorders. 2007 ; 22 (suppl 18). 424-430
8. Rongve A, Boeve BF, Aarsland D. Frequency and correlates of caregiver-reported sleep disturbances in a sample of persons with early dementia. J Am Geriatr Soc. 2010 ; 58 (3). 580-586
9. Rose KM, Beck C, Tsai PF, et al. Sleep disturbances and nocturnal agitation behaviors in older adults with dementia. Sleep. 2011 ; 34 (6). 779-786
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 ; 34 (7). 939-944
11. Caffarra P, Vezzadini G, Dieci F, Zonato F, Venneri A. Rey-Osterrieth complex figure: normative values in an Italian population sample. Neurol Sci. 2002 ; 22 (6). 443-447
12. Caltagirone C, Gainotti G, Masullo C, Miceli G. Validity of some neuropsychological tests in the assessment of mental deterioration. Acta Psychiatr Scand. 1979 ; 60 (1). 50-56
13. Ancoli-Israel S, Vitiello MV. Sleep in dementia. Am J Geriatr Psychiatry. 2006 ; 14 (2). 91-94
14. Tractenberg RE, Singer CM, Kaye JA. Symptoms of sleep disturbances in persons with Alzheimer's disease and normal elder. J Sleep Res. 2005 ; 14 (2). 177-185
15. Creese J, Bedard M, Brazil K, Chambers L. Sleep disturbances in spousal caregivers of individuals with Alzheimer's disease. Int Psychogeriatr. 2008 ; 20 (1). 149-161
16. Ismail Z, Hermann N, Francis PL, et al. A SPECT study of sleep disturbances and Alzheimer's disease. Dement Geriat Cogn Disord. 2009 ; 27 (3). 254-259
17. Levy R, Dubois B. Apathy and functional anatomy of prefrontal cortex-basal ganglia circuits. Cereb Cortex. 2006 ; 16 (7). 916-928
18. Girault JA, Greengard P. The neurobiology of dopamine signalling. Arch Neurol. 2004 ; 61 (5). 641-644
19. Schultz W. Dopamine neurons and their role in reward mechanisms. Curr Opin Neurobiol. 1997 ; 7 (2). 191-197
20. Pritchard AL, Pritchard CW, Bentham P, Lendon CL. Investigation of the role of the dopamine transporter in susceptibility to behavioural and psychological symptoms of patients with probable Alzheimer's disease. Dement Ggeriatr Cogn Disord. 2008 ; 26 (3). 257-260
21. Marshall GA, Fairbanks LA, Tekin S, et al. Neuropathological correlates of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord. 2006 ; 21 (3). 144-147
22. Mitchell RA, Hwerrmann N, Lanctot KL. The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease. CNS Neurosci Ther. 2011 ; 17 (5). 411-427
23. Lanctot KL, Moosa S, Hermann N, et al. A SPECT study of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord. 2007 ; 24 (1). 65-72
24. Schultz W, Dayan P, Montague PR. A neural substrate of prediction and reward. Science. 1997 ; 275 (5306). 1593-1599
25. Murray AM, Weihmueller FB, Marshall JF, Hurtig HI, Gottleib GL, Joyce JN. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism. Ann Neurol. 1995 ; 37 (3). 300-312
26. Pizzolato G, Chierichetti F, Fabbri M, et al. Reduced striatal dopamine receptors in Alzheimer's disease: single photon emission tomography study with the D2 tracer 123I-IBMZ. Neurology. 1996 ; 47 (4). 1065-1068
27. Tanaka Y, Meguro K, Yamaguchi S, et al. Decreased striatal D2 receptor density associated with severe behavioral abnormality in Alzheimer's disease. Ann Nucl Med. 2003 ; 17 (7). 567-573